AbbVie CFO Chase spearheaded its Abbott spinoff and Imbruvica buy—and now he's retiring

AbbVie has been on quite the ride since its spinoff from Abbott, largely thanks to booming growth for its megablockbuster Humira. Now, the company’s chief financial officer is nearly ready to step aside.